# Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

> **NCT00662194** · — · UNKNOWN · sponsor: **Bayside Health** · enrollment: 40 (estimated)

## Conditions studied

- HIV-hepatitis Co-infection
- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00662194
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-03-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662194, "Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00662194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*